Although the trials involved different settings, the data suggested that TCM was both safe and beneficial when combined with conventional antiviral medicine. It was agreed that there are promising data on the benefits of TCM in reducing the disease exacerbation rate for mild and moderate cases of COVID-19. However, evidence on the benefit of TCM injection for severe cases is limited and further evaluation is critically needed.
These were then the subject of discussion by participants who, while recognizing that the studies suggested the benefits of TCM, called for further investigation into the effectiveness of these products in other populations.
It was agreed that international cooperation and trials should be promoted, with reports in line with international reporting standards in order to make the results more widely accessible. This could be done together with TCM hospitals outside China, and in partnership with WHO TCI collaborating centres – identifying potential partners to replicate the most promising studies and producing a comprehensive analysis.
看了一下,这就是个会议记录,讨论中药在抗疫上的作用。然后中国的报告者指出中药结合传统抗病毒药的联合疗法在各个阶段都能起到一定作用。 然后正如上面引用的内容所述,与会者认为基于所呈现的研究材料来看似乎在轻症情况下是有一定作用的,然后建议要在更广的范围做实验以做进一步分析。 |